Skip to main content
OpenTrials

Clinical trial condition

Irritable Bowel Syndrome With Constipation

Explore clinical trials studying Irritable Bowel Syndrome With Constipation. Study availability and eligibility vary by location and protocol.

22 public trials 2 recruiting studies
Refine in advanced search Browse all conditions

Irritable Bowel Syndrome With Constipation trial results

Completed

Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

NCT02559206

Conditions
Irritable Bowel Syndrome With Constipation
Locations
  • Ironwood Investigational Site Huntsville, Alabama, United States
  • Ironwood Investigational Site Phoenix, Arizona, United States
  • Ironwood Investigational Site Tucson, Arizona, United States
  • Ironwood Investigational Site North Little Rock, Arkansas, United States
View all 71 locations
View Trial Details
Completed

An Open-Label, Long-term Study to Assess the Immunogenicity of LINZESS® (Linaclotide) Administered Orally to Adult Participants With Irritable Bowel Syndrome With Constipation or Chronic Idiopathic Constipation

NCT02590432

Conditions
Chronic Idiopathic Constipation, Irritable Bowel Syndrome With Constipation
Locations
  • Pinnacle Research Group, LLC Anniston, Alabama, United States
  • North Alabama Research Center, LLC Athens, Alabama, United States
  • Alliance Clinical Research Childersburg, Alabama, United States
  • G & L Research, LLC Foley, Alabama, United States
View all 79 locations
View Trial Details
Completed

An Open-Label, Long-Term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

NCT00765999

Conditions
Chronic Constipation, Constipation, Irritable Bowel Syndrome With Constipation, +3 more
Locations
  • Innovative Clinical Trials Birmingham, Alabama, United States
  • Parkway Medical Center Birmingham, Alabama, United States
  • Medical Affiliated Research Center, Inc. Huntsville, Alabama, United States
  • Radiant Research, Inc. Chandler, Arizona, United States
View all 118 locations
View Trial Details
Completed

An Open-label, Long-term Safety Study of Linaclotide in Patients With Chronic Constipation or Irritable Bowel Syndrome With Constipation

NCT00730171

Conditions
Chronic Constipation, Irritable Bowel Syndrome With Constipation
Locations
  • Ironwood Investigational Site Birmingham, Alabama, United States
  • Ironwood Investigational Site Huntsville, Alabama, United States
  • Ironwood Investigational Site Chandler, Arizona, United States
  • Ironwood Investigational Site Phoenix, Arizona, United States
View all 116 locations
View Trial Details
Completed

Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)

NCT00938717

Conditions
Irritable Bowel Syndrome With Constipation
Locations
  • Ironwood Investigational Site Birmingham, Alabama, United States
  • Ironwood Investigational Site Huntsville, Alabama, United States
  • Ironwood Investigational Site Phoenix, Arizona, United States
  • Ironwood Investigational Site Tempe, Arizona, United States
View all 107 locations
View Trial Details

Related conditions